drugset / Trial / NCT00051532

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

NCT00051532 ↗

Terminated 700 enrolled LEO Pharma
RandomizedDouble-blindOther

Summary

The purpose of the study is to determine whether seocalcitol is effective in the treatment of advanced primary liver cancer (hepatocellular carcinoma \[HCC\]).

Timeline

Start
1999-09
Primary completion
—
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Seocalcitol Small molecule 5 ug —